BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso

As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-...

January 24, 2023 | News

New Eppendorf Conical Tubes 25 mL variants for even better sample recovery

The innovative material of the amber-colored Conical Tubes 25 mL is highly transparent, while at the same time effectively protecting the sample from low-w...

January 24, 2023 | News

Ingenovis Health Announces New Webinar Series for Clinicians

Top healthcare talent and workforce provider, Ingenovis Health (Ingenovis), is launching a new webinar series for clinicians. The ACT Webinar Series for He...

January 23, 2023 | News

AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender ...

January 23, 2023 | News

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...

January 23, 2023 | News

Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test

The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolutio...

January 23, 2023 | News

Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1

Data derived from the test can help to serve as a critical tool to monitor and help treat HIV-1-infected individuals, as well as inform epidemiologic and g...

January 23, 2023 | News

Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...

January 23, 2023 | News

Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed the c...

January 23, 2023 | News

CureSearch To Lead Impact Study On Cost, Treatment Benefits Of Molecular Testing For Childhood Cancer Patients

Cancer is the number one disease killer in children in the US. Although survival rates for the most common types of childhood cancer have greatly increased...

January 20, 2023 | News

QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs

Start of worldwide diagnostic use follows the launch of upgraded EZ2 Connect for research use in 2021, builds on the success of EZ1 Connect platform foun...

January 19, 2023 | News

Strength in sustainability: Vetter wins gold in EcoVadis ranking

Vetter among the top five percent in the industry Result acknowledges strong sustainability commitment to the environment, social sector and...

January 18, 2023 | News

Bausch + Lomb Acquires AcuFocus, Inc.

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to liv...

January 18, 2023 | News

Speakers Announced for 2023 BIO CEO & Investor Conference

The Biotechnology Innovation Organization (BIO) will hold its CEO & Investor Conference February 6-9, 2023 to bring biotech companies togethe...

January 18, 2023 | News

Stay Connected